S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
pixel
Log in
CVE:NXG

NexgenRx Inc. (NXG.V) Stock Forecast, Price & News

C$0.26
+0.02 (+8.33 %)
(As of 01/15/2021 03:02 PM ET)
Add
Compare
Today's Range
C$0.26
Now: C$0.26
C$0.26
50-Day Range
C$0.00
MA: C$0.22
C$0.26
52-Week Range
C$0.14
Now: C$0.26
C$0.26
Volume4,000 shs
Average Volume25,817 shs
Market CapitalizationC$18.18 million
P/E Ratio15.29
Dividend YieldN/A
BetaN/A
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was founded in 2003 and is headquartered in Toronto, Canada.

MarketRank

Overall MarketRank

1.02 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Health Care Plans
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6953393
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$10.49 million
Cash FlowC$1.20 per share
Book ValueC$0.05 per share

Profitability

Miscellaneous

Market CapC$18.18 million
Next Earnings Date4/8/2021 (Estimated)
OptionableNot Optionable
C$0.26
+0.02 (+8.33 %)
(As of 01/15/2021 03:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NXG News and Ratings via Email

Sign-up to receive the latest news and ratings for NXG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NexgenRx Inc. (NXG.V) (CVE:NXG) Frequently Asked Questions

How has NexgenRx Inc. (NXG.V)'s stock price been impacted by COVID-19 (Coronavirus)?

NexgenRx Inc. (NXG.V)'s stock was trading at C$0.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NXG stock has increased by 44.4% and is now trading at C$0.26.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than NexgenRx Inc. (NXG.V)?

Wall Street analysts have given NexgenRx Inc. (NXG.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NexgenRx Inc. (NXG.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is NexgenRx Inc. (NXG.V)'s next earnings date?

NexgenRx Inc. (NXG.V) is scheduled to release its next quarterly earnings announcement on Thursday, April 8th 2021.
View our earnings forecast for NexgenRx Inc. (NXG.V)
.

How were NexgenRx Inc. (NXG.V)'s earnings last quarter?

NexgenRx Inc. (NXG.V) (CVE:NXG) released its quarterly earnings results on Thursday, November, 19th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $2.65 million for the quarter.
View NexgenRx Inc. (NXG.V)'s earnings history
.

Who are some of NexgenRx Inc. (NXG.V)'s key competitors?

What other stocks do shareholders of NexgenRx Inc. (NXG.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx Inc. (NXG.V) investors own include WestJet Airlines (WJA) and Hydro One Limited (H.TO) (H).

Who are NexgenRx Inc. (NXG.V)'s key executives?

NexgenRx Inc. (NXG.V)'s management team includes the following people:
  • Mr. Ronald C. Loucks, Founder, CEO, Pres & Director (Age 70, Pay $181.2k)
  • Mr. Kelly Ehler CPA, CA, Chief Financial Officer
  • Mr. Andrew Munroe, Director of Operations
  • Mr. Hugh C. Hart, VP of Sales & Account Management
  • Ms. Margaret Ingram, Pharmacist Consultant

What is NexgenRx Inc. (NXG.V)'s stock symbol?

NexgenRx Inc. (NXG.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

How do I buy shares of NexgenRx Inc. (NXG.V)?

Shares of NXG and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is NexgenRx Inc. (NXG.V)'s stock price today?

One share of NXG stock can currently be purchased for approximately C$0.26.

How big of a company is NexgenRx Inc. (NXG.V)?

NexgenRx Inc. (NXG.V) has a market capitalization of C$18.18 million and generates C$10.49 million in revenue each year.

What is NexgenRx Inc. (NXG.V)'s official website?

The official website for NexgenRx Inc. (NXG.V) is www.nexgenrx.com.

How can I contact NexgenRx Inc. (NXG.V)?

NexgenRx Inc. (NXG.V)'s mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The company can be reached via phone at +1-416-6953393.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.